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Background: Since the Japanese government updated the medical practice laws, each
hospital has to submit procedural volume from April 2007 and may sometime in the
future have to submit some outcome indicators. It is very important to examine
whether procedural volume is accurate and appropriate.
Methods: We analyzed 4581 procedures from 36 centers between 2003 and 2005 by
clinical database. The effect of hospital volume on each outcome was tested by a hi-
erarchical mixed-effects logistic regression model, covering clinical risk factors, pro-
cedural year, clinical processes, and hospital volume/surgeon volume as a fixed effect
and random intercepts for sites.
Results: Logistic regression model revealed a significant association between hospital
bypass graft volume and 30-day mortality (P, .05) and operative mortality (P, .01).
Surgeon procedural volume, however, did not have a significant effect on those out-
comes. The effect of hospital procedural volume was associated with better outcomes
in most patient subgroups: age younger than 65 years (P , .05), age 65 years and
older (P , .01), low risk (P 5 .58), and high risk (P , .01).
Conclusion: In Japan, high-volume compared with low-volume providers had better
outcomes. As for public reporting in Japan, hospital-based evaluation might be more
credible than surgeon-based evaluation. Although minimal volume standards might
be effective to improve quality to some extent, volume has limitations as a marker
of quality because of its wide range of variance.
S
ince the Japanese government updated the medical practice laws in June 2006,
each local government has had the power to force medical centers to submit and
bring forward ‘‘certain information’’ that is useful for patients choosing a hos-
pital from April 2007 (http://www.mhlw.go.jp/topics/bukyoku/soumu/houritu/dl/
164-4a.pdf).
As of January 2007, ‘‘certain information’’ includes procedural volume but few
outcome indicators, such as operative mortality rate or morbidity rate. However, there
is the possibility that ‘‘certain information’’ could include surgeon-specific outcome
indicators similar to public reporting in New York State.1,2 In Japan, it is very impor-
tant to examine whether procedural volume is information that is appropriate to reveal
and whether it is accurate.
Measuring and understanding the association between surgical volume and out-
come in the delivery of health services has been the focus of much research since
the 1980s in the United States.3,4 Recently, two systematic reviews suggested that
high volume is associated with better outcomes, but the degree of this association
varies greatly.5,6 As the complications included in these findings are partly due to
methodologic shortcomings in many studies, it is very important to conduct a rigorous
examination of volume-outcome association.
In Japan, whereas 9 studies suggest that a significant relationship between volume
and outcomes does exist,7-15 4 studies suggest that no such relationship exists.16-19
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Moreover, none of those Japanese studies examines the rela-
tionships of hospital and physician volume, appropriateness
of patient selection, or risk adjustment by risk model with
good calibration (Hosmer–Lemeshow test positive) and dis-
crimination (C-index. 0.75). No association between hospi-
tals’ coronary artery bypass graft (CABG) surgery volume
and outcome has been reported in Japan.
We undertook a contemporary examination of the associ-
ation between hospital CABG procedural volume and out-
come using clinical data available from the Japanese Adult
Cardiovascular Surgery Database (JACVSD). The data col-
lection form is almost identical with that of The Society of
Thoracic Surgeons (STS) National Cardiac Database. We
examined whether hospital volume and surgeon volume
were associated with each outcome category (30-day mortal-
ity, 3-day operative mortality). We also examined how the
association between hospital CABG volume and operative
mortality varied as a function of patient age and predicted
surgical risk.
As JACVSD participating hospitals did not cover all cen-
ters in Japan, we also examined the database of the Japanese
Association for Thoracic Surgery (JATS). Although it was
hard to adjust patient preoperative risk because of its aggre-
gate data form, the JATS survey covered nearly all centers
in Japan. We considered the nationwide trend and the poten-
tial health policy implications of using hospital volume in the
context of health policy.
Methods
Survey 1 (JATS Database)
Study population. Since 1986, the JATS has conducted annual
surveys of thoracic surgery. JATS sent out survey questionnairesThe Journal of Thorato all institutions conducting cardiovascular surgery in Japan, and
the response rates of the survey were very high (95.9% in 2001,
97.4% in 2002, 94.3% in 2003, and 90.3% in 2004).20-23 The defi-
nitions of terms are based on the published guidelines of the STS and
The American Association for Thoracic Surgery.24 We examined
isolated CABG surgery procedures, excluding those combined
with valve or other major surgical interventions, performed between
January 1, 2001, and December 31, 2004. We included 540 centers
that reported at least one CABG procedure during 2001 through
2004. Because of the very high response rate of the JATS survey,
540 centers represent nearly all institutions in Japan doing coronary
procedures.
Statistical analysis. The primary yardstick of outcome used by
JATS was 30-day mortality, defined as death within 30 days of
operation, regardless of the patient’s geographic location. Although
this criterion includes death within 30 days of operation even when
the patient had been discharged from the hospital during those 30
days, patients who died in the hospital at greater than 30 days
were ungraspable in the JATS survey. Hospital-isolated CABG an-
nual case volume was averaged over a 4-year period (2001–2004)
to increase its stability. Annual hospital procedural volume was di-
vided into quarters (15#, 16–30, 31–50, and.50). The break points
were chosen to form 4 fairly equal-sized hospital samples, and sim-
ilar volume differences were maintained among the groups.We sim-
ply showed average mortality rate (and 95% confidence interval) per
hospital (Table 1).
Survey 2 (JACVSD)
Study population. The JACVSD was established in 2000 to re-
port surgical outcomes after cardiothoracic procedures in detail. The
database currently captures clinical information from 151 hospitals
(28.5% of all centers performing CABG surgery). The data collec-
tion form has 255 variables in total, and these variables are almost
identical to the STS National Database (available online at http://
wts.org). The definitions of JACVSD variables (available online
at http://www.jacvsd.umin.jp) are the same as those of the STS Na-
tional Database. JACVSD constructed the software for the Web-
based data collection system, and through this system each data
manager in the participating hospitals submits data by computer. Al-
though participation in the JACVSD is voluntary, data completeness
is high, with overall preoperative risk factors used in risk models
missing in fewer than 2%. The accuracy of the submitted data is
checked through data auditing in monthly visits to each hospital
by administrative office members. After checking the data usingTABLE 1. Hospital outcomes and characteristics in JATS database (2001–2004)
Hospital CABG volume (procedures per year)
$15 16–30 31–50 #51 Overall
No. of patients 4,140 13,589 19,337 45,545 82,611
No. of hospitals 133 153 123 131 540
Status emergency 295 1,727 3,141 6,393 11,556
Thirty-day mortality 124 349 412 700 1,585
Emergency rate, % 7.1 12.7 16.2 14.0 14.0
Total mortality rate, % 3.00 2.57 2.13 1.54 1.92
Average mortality rate, % (95% CI) 3.79 (2.11–5.48) 2.60 (2.17–3.01) 2.17 (1.85–2.49) 1.61 (1.80–1.43)
CI, Confidence interval.cic and Cardiovascular Surgery c Volume 135, Number 6 1307
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Hospital CABG volume (procedures per year)
16–30 31–50 $51 All
No. of patients 894 1645 2042 4581
No. of hospitals 13 14 9 36
Age, median (IQR) 69.0 (63–75) 69.0 (62–74) 69.0 (61–74) 69.0 (62–74)
Preop creatine, median (IQR) 0.9 (0.7–1.2) 0.9 (0.8–1.1) 0.9 (0.8–1.1) 0.9 (0.8–1.1)
Men, % 78.2 76.7 76.9 77.1
Chronic lung disease, % 7.4 5.0 5.5 5.7
Cerebrovascular disease, % 10.0 11.8 12.3 11.7
Hypertension, % 77.4 70.2 70.5 71.7
Diabetes, % 48.2 47.8 46.2 47.2
Left main artery disease, % 38.6 31.2 36.1 34.9
Three-vessel disease, % 69.7 68.8 66.3 67.8
NYHA class IV, % 12.9 12.3 8.4 10.7
Congestive heart failure, % 16.3 17.9 11.6 14.8
Shock, % 5.7 6.1 3.6 4.9
Reoperation, % 3.5 3.9 2.4 3.1
Emergency/salvage, % 7.8 7.4 7.3 7.5
Preoperative risk, % 2.4 2.0 1.7 2.0
Thirty-day mortality 2.68 1.95 1.47 1.88
Operative mortality 4.14 2.86 1.62 2.55
IQR, Interquartile range;NHYA,New York Heart Association. Preoperative risk was calculated on the basis on JACVSD 30-day mortality risk model. Number of
patients is for 3-year periods (2003–2005).the clinical records and operative notes, the audit members suggest
that the hospital data manager complete and improve the data entry.
The registration rate of JACVSD data has further been confirmed in
independent comparisons of hospital CABG surgery volume sub-
mitted to the JACVSD against those reported to the JATS database.
We excluded 11 centers that entered data for fewer than of the total
number of cases compared with those in the JATS database. Inclu-
sion of cases from these excluded centers strengthened the effect of
procedural volume on outcome.
We examined isolated CABG surgery procedures, excluding
those combined with valve surgery or other major surgical interven-
tions, performed between January 1, 2003, and December 31, 2005.
Fifty centers were members of JACVSD as of January 1, 2003. After
excluding 11 centers for the aforementioned reason and excluding 3
centers because of extremely low CABG volume (reported , 15
CABG procedures per year), we ultimately included the data from
36 centers (Table 2).
TABLE 3. The effect of volume index on each outcome
Volume index (procedures per year)
Thirty-day
mortality
Operative
mortality
Hospital adult cardiac surgery volume ,.05 ,.01
Hospital CABG-related surgery volume ,.05 ,.01
Hospital CABG isolated volume ,.05 ,.01
Surgeon adult cardiac surgery volume NA NA
Surgeon CABG-related surgery volume NA NA
Surgeon CABG isolated volume NA NA
CABG, Coronary artery bypass grafting; NA, not significant.1308 The Journal of Thoracic and Cardiovascular Surgery c JuStatistical analysis. The primary outcome measure of JACVSD
analysis was 30-day operative mortality, defined as in-hospital or
30-day mortality, whichever was longer.25 The annual case volumes
of hospitals and surgeons were averaged over a 3-year period
(2003–2005) with a view to maintaining stability. Although volume
was considered to be a continuous variable in this analysis, the pa-
tient and hospital characteristics and unadjusted outcomes were cat-
egorized by annual hospital procedural volume for display purposes.
The break points were identical with those of JATS analysis (16–30,
31–50, and .50).
The effect of hospital volume on unadjusted outcomes was tested
by a hierarchical mixed-effects logistic regression model. We exam-
ined the 6 types of volume index in this study: hospital adult cardiac
surgery volume (CABG, valve, thoracic aorta, and other proce-
dures), hospital CABG-related surgery volume (CABG plus valve
or other procedures), CABG-only surgery volume per hospital, adult
cardiac surgery volume per surgeon, CABG-related surgery volume
per surgeon, and CABG-only surgery volume per surgeon (Table 3).
In Japan, isolated CABG surgery accounts for 48% of all adult car-
diac surgery, while 29% was valvular heart disease and 19% was
thoracic aortic aneurysm.22 These analyses included previously
identified clinical risk factors,1 procedure year, clinical process
(off-pump CABG surgery, autologous blood transfusion), hospital
procedural volume, surgeon volume as a fixed effect, and random
intercepts for sites.26 The C-indexes for this model in the study
1Motomura N, Miyata H, Takamoto S, Tsukihara H, Okada M, Japan Cardiovas-
cular Surgery Database Organization. Japan Adult Cardiovascular Surgery Data-
base: 30-day Operative Mortality and Morbidity Risk Models of CABG-only
Surgery. Unpublished data.ne 2008
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Hospital CABG volume (procedures per year)
16-30 31-50 $51 Overall
Surgeon CABG volume (procedures per year) % n % n % n % n
.15 3.47 425 2.52 576 1.70 329 2.68 1330
$16 2.05 469 1.90 1069 1.46 1713 1.73 3251
Overall 2.67 894 2.14 1645 1.50 2042
Number of patients is for 3-year periods (2003–2005).A
CDpopulation were 0.83 for 30-day mortality and 0.84 for 30-day op-
erative mortality.
As for 30-day operative mortality, we also presented volume in-
teraction per hospital volume3 surgeon volume (Table 4) and con-
ducted subgroup analyses for patient age (,65 years and$65 years;
Table 5) and patient preoperative risk (Table 6). Risk-adjusted mor-
tality rates for each category were calculated by dividing the ob-
served mortality rate by the expected mortality rate at the same
hospital and multiplying by the overall CABG mortality rate of
the JACVSD.
Results
Survey 1 (JATS Database)
Between January 1, 2001, and December 31, 2004, 82,611
isolated CABG procedures were performed at 540 hospitals
in Japan. Average hospital procedural volumes ranged from
0.25 to 292.75 isolated CABG procedures (median, 28; inter-
quartile range, 15–49). In Japan, 30 (5.6%) centers performed
100 or more procedures per year and 133 (24.6%) centers
performed fewer than 15 procedures per year. Table 1 dis-
plays hospital outcomes and characteristics in the JATS data-
base. High-volume hospitals (those performing . 50
procedures per year [n 5 131]) had significantly lower mor-
tality rates than those in the other 3 categories. Low-volume
hospitals (those performing # 15 procedures per year [n 5
133]) were more likely to operate in elective cases. As for
the JATS database, we also showed unadjusted 30-day mor-
tality rates by procedural volume at 10 intervals (Figure 1).
The mortality rate in hospitals performing 41 to 50 CABG
procedures per year was 1.91%, and all mortality rates ofThe Journal of Thorthe following categories (51–60, 61–70, 71–80, 81–90, 91–
100, and $101 procedures/year) were lower than 2.0%.
Survey 2 (JACVSD)
Table 2 displays the patient characteristics and outcomes of
the JACVSD as a function of hospital volume. Between
2003 and 2005, 4581 isolated CABG operations were per-
formed at 36 participating hospitals. Thirteen of the JACVSD
participating hospitals, involving 894 patients, were catego-
rized as medium- to low-volume hospitals (16–30 procedures
per year); 14 hospitals, with 1645 CABG patients, were cat-
egorized as medium- to high-volume hospitals (31–50 proce-
dures per year); and 9 hospitals, with 2042 CABG patients,
were categorized as high-volume (.50 procedures per
year) hospitals. The medium- to low-volume hospitals were
more likely than high-volume centers to operate on patients
with chronic lung disease, on patients with hypertension or
congestive heart failure, and in emergency or salvage cases.
On the basis of preoperative risk factors, the average ex-
pected surgical mortality risk rates were 2.4% in medium-
to low-volume hospitals, 2.0% in medium- to high-volume
hospitals, and 1.7% in high-volume hospitals. Overall, there
were 86 cases of 30-day mortality and 117 of 30-day opera-
tive mortality (31 patients died in the hospital at. 30 days).
These outcome rates declined in high-volume hospitals in
comparison with middle- to low-volume hospitals.
Table 3 displays the effect of volume index on each out-
come. Only hospital procedural volume affected 30-day
mortality and operative mortality significantly. Table 4 dem-
onstrates the effect of hospital and surgeon proceduralTABLE 5. Unadjusted and risk-adjusted mortality by patient age group (n 5 4581)
Age < 65 years Age $65 years
Hospital CABG volume Hospital CABG volume
16–30 31–50 $50 16–30 31–50 $50
No. of patients 287 559 725 607 1086 1317
Unadjusted mortality 2.79 1.61 1.24 4.78 3.50 1.82
Risk-adjusted mortality 1.53 1.23 1.03 3.28 2.62 1.73
P value (hospital volume)
,.05 ,.01
Number of patients is for 3-year periods (2003–2005).acic and Cardiovascular Surgery c Volume 135, Number 6 1309
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Expected risk < 1.5% Expected risk > 1.5%
Hospital CABG volume Hospital CABG volume
16–30 31–50 $50 16–30 31–50 $50
No. of patients 432 921 1252 462 724 790
Unadjusted mortality 0.69 0.98 0.16 7.36 5.25 3.92
Risk-adjusted mortality 0.37 0.55 0.09 5.22 3.81 3.25
P value (hospital volume) NA ,.01
Preoperative risk was calculated based on JACVSD 30-day mortality risk model. Results were further adjusted with risk group to ensure constant risk profiles.
Number of patients is for 3-year periods (2003–2005).volume on risk-adjusted 30-day operative mortality rates. As
there was colinearity between these factors (r5 0.385), only
hospital procedural volume had a significant effect on 30-day
operative mortality (P, .001). Overall, the highest mortality
rates (3.47%) were observed when patients were treated by
low-volume surgeons at middle- to low-volume hospitals,
and the best results (1.46%) were obtained by high-volume
surgeons at high-volume hospitals. We have shown the effect
of volume on outcome in patient subgroups (Tables 5 and 6).
Regarding the patient age group, the effect of hospital vol-
ume was apparent in both groups (age , 65 years, P ,.05;
age$ 65 years, P, .01). Patients at expected high operative
risk (.1.5%, P, .01) demonstrated consistently lower mor-
tality when treated at higher-volume centers. In contrast,
among those with a risk of less than 1.5%, there was not a sig-
nificant volume effect on 30-day operative mortality rates.
Discussion
Both JATS and JACVSD analyses demonstrated an associa-
tion between hospital CABG procedural volume and CABG
outcome. Although high-quality evaluations of CABG
volume–outcome relationships using data from the STS Na-
tional Cardiac Database27 also found an association between
volume and outcome, the effects of hospital volume were
modest compared with our findings. This may be partly
due to the straightforward case mix across volume category
(Table 2) or the different distribution of hospital CABG pro-1310 The Journal of Thoracic and Cardiovascular Surgery c Jcedural volume in each country. As 4 fairly equal-sized hos-
pital volume break points were 150 or less, 150 to 300, 300 to
450, and greater than 450 in the United States, 98.3% of Jap-
anese centers would be categorized as low-volume hospitals
by the US definition. In Japan, there are no standards for
opening a cardiac surgery program; they simply proliferate
without any regulatory oversight. Although low-volume car-
diac surgery programs are loss-making of themselves, many
hospitals want a cardiac surgery program not only for the
backup of percutaneous coronary intervention but also for
prestige as a general hospital. Our results suggest that mini-
mal volume standards of cardiac surgery would be an effec-
tive way to improve CABG outcomes.
The outcome improvement shown in Figure 1 also sug-
gested that the effect of the hospital volume learning curve
might be stronger in lower volume distribution in Japan.
The reason for the difference regarding volume effect be-
tween Japan and other countries may be multifactorial. As
many surgeons belong to a single hospital in Japan, informa-
tion and experiences of conferences on each patient are
shared with many cardiac surgeons and other medical staffs
in the hospital. Usually, cardiac surgery is performed not
by a single consultant but by two or more consultant surgeons
with trainees. Characteristics of the Japanese health insurance
system might be another reason, because insurance covers
a large part of the medical expense with a small individual
payment at each operation.28 Patients can stay in the hospitalFigure 1. Unadjusted 30-day mortality
rates by CABG procedural volume in
JATS database (2001–2004).une 2008
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and they can choose any surgeon and hospital they prefer, re-
gardless of their insurance. Surgeons can conduct surgical
and medical treatments at the maximum level with less pres-
sure from the hospital and insurance company compared with
surgeons in other countries. Moreover, postoperative care in
the intensive or critical care unit is maintained mainly by phy-
sicians and not by nursing staffs in Japan, which may lead to
better care than otherwise.29 Because of these differences,
minimal volume standards for CABG surgery in Japan might
be preferable at lower levels than those in the United States.
As noted in previous studies by Peterson,27 Hannan,30 and
their associates, Table 4 shows that even for very low numbers
of cases, low-volume surgeons have substantially better results
when they operate at higher-volume hospitals. High-volume
hospitalsmight also be important as teaching institutes. Tables
5 and 6 show that the volume–outcome relationship may be
most evident for higher risk patients (older, more comorbid-
ities). In addition to regionalization of cardiac surgery, patient
transfer system (eg, transferring high-risk patients to high-
volumehospitals quickly) also needs to be developed for better
quality of cardiac surgery in Japan.
As for public reporting, hospital-based evaluationmight be
more relevant than surgeon-based evaluation. Hospital vol-
ume index (total adult cardiac procedure volume, hospital
CABG-related surgery procedural volume, and hospital
CABG-only procedural volume) was significantly associated
with 30-day mortality and operative mortality. On the other
hand, the surgeon–volume index was not significantly associ-
atedwith these outcomes. Inasmuch as there are few open-bed
hospitals andmost surgeons and their teams belong to a single
hospital in Japan, a large proportion of surgeon volumemight
be accounted for by hospital volume. Other studies suggest
that individual report cards might discourage surgeons from
operating on high-risk patients, because it is surgeons, not
hospitals, that choose whether or not to accept a patient for
surgery.1,2 As for the public reporting regarding outcomes
of cardiac surgery in Japan, releasing a hospital-based out-
come might be more preferable.
In 2002, the Japanese Ministry of Health, Labor and Wel-
fare set minimal standards by references to hospital proce-
dure volume for medical treatment fees on surgery.31 As
for cardiac surgery, medical institutes in which the annual
cardiac surgery procedural volume was less than 100 had
their medical treatment fees lowered by 30%. As many stake-
holders objected, these standards were suspended in 2006.
Minimal volume standards for CABG surgery in Japan
may also be modest not only because most medical institutes
(over 60%) had been lowered by those standards32 but also
because of the limitation of procedural volume as a marker
of CABG quality. Even when a significant association exists,
hospital volume is not a complete predictor of outcome for
individual hospitals. Inasmuch as hospital procedural volume
embraces physicians’ skills, experienced interdisciplinaryThe Journal of Thorteams, well-organized care processes, and hospital facilities,
it is a necessary factor when outcomes are considered. How-
ever, many other parameters (namely, outcome monitoring,
compliance with process measures, appropriateness of pa-
tient selection for surgery) may also be associated with better
outcomes.1,33 Thus volume alone is not sufficient for predict-
ing outcome in Japan. In addition, there was wide variance in
the results observed among individual centers, particularly
those in the low-volume category (Table 1), indicating that
not all high-volume providers have better outcomes and not
all low-volume providers have worse outcomes. Further stud-
ies should include an examination of those parameters to im-
prove the outcomes of individual centers.
Outcome-based evaluation is also an important way to im-
prove quality of CABG surgery. However, surgical mortality
has several limitations as an indicator of hospital quality un-
der the present circumstances in Japan because small sample
size and low event rates combine to diminish statistical
power.34 Although volume is not a complete indicator of
quality, high-volume providers have, on the whole, better
outcomes than low-volume providers. In addition, the effect
of hospital procedural volume was significantly associated
with better outcomes in almost all patient subgroups (except
for low-risk surgery). Regionalization of medical centers on
the basis of hospital procedural volume might be effective
to improve quality to some extent. However, regionalization
has an impact not only on hospital quality, but also on pa-
tients’ access, staffing of medical professionals, cooperation
with other departments in the hospital, and health care expen-
diture. As for specific health policy recommendations, further
analysis is needed to consider these factors. When case loads
become large enough to support outcome measurement
through regionalization, it is also feasible to base quality as-
sessments on both outcome data and volume (or on one of
these).
Several limitations should be noted. In the JACVSD anal-
ysis, we excluded centers that submitted fewer than JATS
results, because the appropriateness of patient selection for
procedural conditions seemed to be important for a volume–
outcome study. A former study also found that high-volume
surgeons performed a higher proportion of operations for
which the indications were inappropriate than low-volume
surgeons.35 It is probably appropriate for fair comparison to
exclude centers whose reporting is incomplete. Moreover,
improving quality of the database is a continuing issue in
JACVSD. As for data accuracy, not only data auditing
but also to educate each site’s input data in correct definition
is important.
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